Exosome-mediated radioprotection: multimodal mechanisms and therapeutic innovations
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.116263 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Rongfan Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China. Hauptthemen laut MEDLINE: Exosomes, Radiation Injuries, Radiation-Protective Agents, Neoplasms. Die Arbeit nennt 115 Literaturangaben. Gefördert von: Science and Technology Project of Nantong City, Government of Jiangsu Province, Jiangsu Commission of Health.
Abstract (Originalsprache)
Although there are already treatments for radiation damage, including stem cell transplantation, standard cancer treatments that may impair the growth and development of healthy cells have a number of disadvantages, such as severe immunological rejection and numerous side effects. With their cell-free properties, exosomes have demonstrated significant therapeutic potential as a novel treatment approach for radiation-induced tissue damage. Because of their effective tissue penetration, targeting specificity, and the protective nature of their natural phospholipid bilayer structure, exosomes have the potential to become a drug-targeted delivery system for radiation therapy and a biomarker for radiation damage in addition to influencing the damaged tissues by controlling DNA damage, oxidative stress, immune response, and inflammatory response to lessen the negative effects of radiation damage on patients. Exosomes are anticipated to play a major role in the prevention and treatment of radiation damage, leading to new advancements in cancer treatment and nuclear disaster response, provided that technological advancements and related challenges, such as the diversity of contents, the lack of quality control, and safety issues, are resolved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China.
- Department of Stomatology, School of Medicine, Nantong University, Nantong 226000, China.
- Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China. Electronic address: ntfywcf@ntu.edu.cn.
- Department of Stomatology, Affiliated Hospital of Nantong University, Nantong 226001, China. Electronic address: fengguijuan2013@ntu.edu.cn.
Förderung
- Science and Technology Project of Nantong City
- Government of Jiangsu Province
- Jiangsu Commission of Health
Zitieren
APA
Xu, R., Qiu, Y., Xu, T., Wang, C., & Feng, G. (2026). Exosome-mediated radioprotection: multimodal mechanisms and therapeutic innovations. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116263
Vancouver
Xu R, Qiu Y, Xu T, Wang C, Feng G. Exosome-mediated radioprotection: multimodal mechanisms and therapeutic innovations. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.116263
BibTeX
@article{Xu2026,
author = {Xu, Rongfan and Qiu, Yi and Xu, Teng and Wang, Chenfei and Feng, Guijuan},
title = {Exosome-mediated radioprotection: multimodal mechanisms and therapeutic innovations},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.116263}
}
EUVIMED